Oppenheimer (NYSE:OPY) Issues Earnings Results

Oppenheimer (NYSE:OPY) issued its quarterly earnings data on Friday. The financial services provider reported $4.21 EPS for the quarter, Zacks reports. The firm had revenue of $445.10 million during the quarter. Oppenheimer had a return on equity of 16.10% and a net margin of 9.06%.

Oppenheimer Stock Down 7.2%

Shares of NYSE OPY opened at $106.23 on Friday. Oppenheimer has a twelve month low of $59.54 and a twelve month high of $118.77. The stock’s 50 day moving average price is $95.11 and its 200-day moving average price is $81.36. The company has a market capitalization of $1.14 billion, a PE ratio of 8.15 and a beta of 1.19.

Oppenheimer Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, May 15th. This is a boost from Oppenheimer’s previous quarterly dividend of $0.18. Oppenheimer’s dividend payout ratio (DPR) is presently 5.52%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on OPY. Cantor Fitzgerald lowered Oppenheimer to a “buy” rating in a report on Wednesday, January 7th. Weiss Ratings raised Oppenheimer from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, April 21st. Finally, Wall Street Zen raised Oppenheimer from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 7th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy”.

Insider Buying and Selling at Oppenheimer

In other news, insider Dennis P. Mcnamara sold 4,673 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $90.67, for a total value of $423,700.91. Following the transaction, the insider owned 20,177 shares in the company, valued at $1,829,448.59. The trade was a 18.80% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 34.86% of the stock is owned by insiders.

Hedge Funds Weigh In On Oppenheimer

Hedge funds and other institutional investors have recently modified their holdings of the business. Arax Advisory Partners boosted its stake in shares of Oppenheimer by 47,700.0% in the 4th quarter. Arax Advisory Partners now owns 478 shares of the financial services provider’s stock worth $35,000 after buying an additional 477 shares during the last quarter. Barclays PLC purchased a new position in shares of Oppenheimer in the 4th quarter worth approximately $40,000. Tower Research Capital LLC TRC purchased a new position in shares of Oppenheimer in the 2nd quarter worth approximately $49,000. Quantbot Technologies LP purchased a new position in shares of Oppenheimer in the 2nd quarter worth approximately $112,000. Finally, State of Tennessee Department of Treasury purchased a new position in shares of Oppenheimer in the 4th quarter worth approximately $147,000. Hedge funds and other institutional investors own 32.26% of the company’s stock.

More Oppenheimer News

Here are the key news stories impacting Oppenheimer this week:

• Positive Sentiment: Revenue growth: Oppenheimer reported quarterly revenue of $445.1M (up ~21% YoY), showing continued top-line strength that supports long‑term business demand. Oppenheimer Holdings Inc. Reports First Quarter 2026 Earnings
• Positive Sentiment: Institutional buying: Several large funds increased positions in Q4 2025 (e.g., Millennium, State Street), indicating some investor confidence at institutional levels. Oppenheimer Holdings Inc. (OPY) Stock Falls on Q1 2026 Earnings
• Neutral Sentiment: Analyst & research activity largely concerns Oppenheimer’s coverage of other stocks (e.g., coverage on small‑caps and tech names) rather than changes to Oppenheimer’s own guidance — limited direct impact on OPY fundamentals. Why Climb Bio (CLYM) is One of the Best Performing Small Cap Stocks So Far in 2026
• Negative Sentiment: Profitability shock: The company reported a net loss of $20.6M (‑$1.93/share) in Q1 2026 versus net income in the year‑ago quarter, and an operating loss — a clear earnings miss that pressured the stock. Oppenheimer Holdings Inc. Reports First Quarter 2026 Earnings
• Negative Sentiment: Cash burn & balance sheet items: Q1 cash used in operations was large (reported ~‑$190M), capex jumped (~$60M), cash on hand fell to roughly $34.6M and total liabilities rose — raising short‑term liquidity and execution concerns. Oppenheimer Holdings Inc. (OPY) Stock Falls on Q1 2026 Earnings
• Negative Sentiment: Insider sale & short interest: A small insider sale was reported and short interest has risen materially, both of which can amplify downward pressure on the stock in the near term. Oppenheimer Holdings Inc. (OPY) Stock Falls on Q1 2026 Earnings Oppenheimer Holdings, Inc. (NYSE:OPY) Sees Large Increase in Short Interest

About Oppenheimer

Oppenheimer & Co Inc is a full-service investment bank and wealth management firm headquartered in New York City. Founded in the mid-20th century, the company provides a broad array of financial services to individual, institutional and corporate clients. Its core competencies include equity and fixed-income research, institutional sales and trading, underwriting and merger-and-acquisition advisory.

In the wealth management segment, Oppenheimer offers tailored investment solutions, comprehensive financial planning and retirement strategies.